SG Americas Securities LLC Sells 140,459 Shares of Amedisys, Inc. (NASDAQ:AMED)

SG Americas Securities LLC cut its position in Amedisys, Inc. (NASDAQ:AMED) by 71.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 56,254 shares of the health services provider’s stock after selling 140,459 shares during the quarter. SG Americas Securities LLC’s holdings in Amedisys were worth $5,107,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in AMED. HBW Advisory Services LLC bought a new stake in Amedisys during the 4th quarter valued at approximately $38,000. Versant Capital Management Inc raised its stake in Amedisys by 68.5% during the 4th quarter. Versant Capital Management Inc now owns 450 shares of the health services provider’s stock valued at $41,000 after purchasing an additional 183 shares during the last quarter. KBC Group NV bought a new stake in Amedisys in the 3rd quarter valued at $63,000. Signaturefd LLC grew its position in Amedisys by 20.9% in the 3rd quarter. Signaturefd LLC now owns 1,367 shares of the health services provider’s stock worth $132,000 after purchasing an additional 236 shares during the last quarter. Finally, CWM LLC increased its holdings in shares of Amedisys by 14.5% during the 3rd quarter. CWM LLC now owns 2,190 shares of the health services provider’s stock worth $211,000 after purchasing an additional 277 shares during the period. 94.36% of the stock is owned by institutional investors and hedge funds.

Amedisys Stock Up 0.2 %

NASDAQ AMED opened at $92.80 on Friday. Amedisys, Inc. has a twelve month low of $82.15 and a twelve month high of $98.95. The stock has a market cap of $3.04 billion, a PE ratio of 36.83, a PEG ratio of 1.83 and a beta of 0.72. The firm has a 50-day simple moving average of $89.17 and a 200 day simple moving average of $94.20. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19.

Amedisys (NASDAQ:AMED) last announced its quarterly earnings data on Wednesday, November 6th. The health services provider reported $1.00 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.19). The firm had revenue of $587.67 million for the quarter, compared to analyst estimates of $586.75 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. Amedisys’s revenue for the quarter was up 5.7% compared to the same quarter last year. During the same period in the previous year, the business posted $0.98 EPS. On average, research analysts forecast that Amedisys, Inc. will post 4.43 EPS for the current year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.